 | Monopar Therapeutics Inc. | |||
| NCM : MNPR || Location: United States | ||||
$0.64-0.04 (-5.59%) |
0.03 M | 0.62 - 0.68 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.170 M |
| March 15, 2024 | 0.230 M |
| Feb. 29, 2024 | 0.849 M |
| Feb. 15, 2024 | 0.063 M |
| Jan. 31, 2024 | 0.022 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.16 | -0.12 | 24.10% |
| 09/30/2023 | -0.17 | -0.14 | 19.26% |
| 06/30/2023 | -0.19 | -0.16 | 14.76% |
| 03/31/2023 | -0.23 | -0.19 | 16.08% |
| 12/31/2022 | -0.21 | -0.23 | -10.00% |
MNPR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 17.455M | Shares Float | 8.313M |
| Short Float | 0.170M | Market Cap | 11.87M |
| Institution ownership | 1.55% | Insider ownership | 52.352% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.61 | Forward EPS | -0.45 |